COVID-19 in MS and NMOSD: A multicentric online national survey in Chile.
作者信息
Ciampi Ethel, Uribe-San-Martín Reinaldo, Soler Bernardita, Fernández Ramiro, García Pía, Navarrete-Asenjo Claudio, Tirapegui José Miguel, Torres Rubén, Polanco Juan, Suárez Felipe, Cuello María José, Cárcamo Claudia
机构信息
Neurology, Pontificia Universidad Católica de Chile, Santiago, Chile; Neurology, Hospital Dr. Sótero del Río, Santiago, Chile.
Neurology, Pontificia Universidad Católica de Chile, Santiago, Chile; Neurology, Hospital Dr. Sótero del Río, Santiago, Chile.
出版信息
Mult Scler Relat Disord. 2020 Oct;45:102392. doi: 10.1016/j.msard.2020.102392. Epub 2020 Jul 12.
Abstract
摘要
相似文献
1
COVID-19 in MS and NMOSD: A multicentric online national survey in Chile.智利多发性硬化症和视神经脊髓炎谱系疾病中的2019冠状病毒病：一项多中心全国在线调查
Mult Scler Relat Disord. 2020 Oct;45:102392. doi: 10.1016/j.msard.2020.102392. Epub 2020 Jul 12.
2
COVID-19 pandemic: The experience of a multiple sclerosis centre in Chile.新冠疫情：智利一家多发性硬化症中心的经历
Mult Scler Relat Disord. 2020 Jul;42:102204. doi: 10.1016/j.msard.2020.102204. Epub 2020 May 16.
3
Risk of COVID-19 infection in MS and neuromyelitis optica spectrum disorders.多发性硬化症和视神经脊髓炎谱系疾病患者感染 COVID-19 的风险。
Neurol Neuroimmunol Neuroinflamm. 2020 Jun 4;7(5). doi: 10.1212/NXI.0000000000000787. Print 2020 Sep.
4
Management of central nervous system demyelinating diseases during the coronavirus disease 2019 pandemic: a practical approach.2019冠状病毒病大流行期间中枢神经系统脱髓鞘疾病的管理：一种实用方法。
Arq Neuropsiquiatr. 2020 Jul;78(7):430-439. doi: 10.1590/0004-282X20200056. Epub 2020 Jul 1.
5
The impact of COVID-19 on patients with neuromyelitis optica spectrum disorder; a pilot study.COVID-19 对视神经脊髓炎谱系疾病患者的影响：一项初步研究。
Mult Scler Relat Disord. 2020 Oct;45:102347. doi: 10.1016/j.msard.2020.102347. Epub 2020 Jun 30.
6
Changes in patient and physician attitudes resulting from COVID-19 in neuromyelitis optica spectrum disorder and multiple sclerosis.新型冠状病毒肺炎导致视神经脊髓炎谱系障碍和多发性硬化症患者及医生态度的变化。
Mult Scler Relat Disord. 2020 Jul;42:102259. doi: 10.1016/j.msard.2020.102259. Epub 2020 Jun 3.
7
Screening neuromyelitis optica patients for COVID-19 infection.对视神经脊髓炎患者进行新型冠状病毒肺炎感染筛查。
Autoimmun Rev. 2020 Nov;19(11):102669. doi: 10.1016/j.autrev.2020.102669. Epub 2020 Sep 14.
8
The COVID-19 pandemic and the use of MS disease-modifying therapies.新冠疫情与多发性硬化症疾病修正疗法的使用
Mult Scler Relat Disord. 2020 Apr;39:102073. doi: 10.1016/j.msard.2020.102073. Epub 2020 Mar 27.
9
Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia.多发性硬化症、视神经脊髓炎谱系疾病和 COVID-19：捷克的大流行之年。
Mult Scler Relat Disord. 2021 Sep;54:103104. doi: 10.1016/j.msard.2021.103104. Epub 2021 Jun 24.
10
Are patients with multiple sclerosis (MS) at higher risk of COVID-19 infection?患有多发性硬化症（MS）的患者感染新冠病毒（COVID-19）的风险更高吗？
Neurol Sci. 2020 Sep;41(9):2315-2316. doi: 10.1007/s10072-020-04570-8. Epub 2020 Jul 7.
引用本文的文献
1
Multiple sclerosis and COVID-19: a northern China survey.多发性硬化症与2019冠状病毒病：一项中国北方地区的调查
Neurol Sci. 2024 Aug;45(8):3563-3571. doi: 10.1007/s10072-024-07578-6. Epub 2024 May 9.
2
Occupational outcomes of people with multiple sclerosis during the COVID-19 pandemic: a systematic review with meta-analysis.COVID-19 大流行期间多发性硬化症患者的职业结果：系统评价和荟萃分析。
Front Public Health. 2023 Nov 27;11:1217843. doi: 10.3389/fpubh.2023.1217843. eCollection 2023.
3
Prevalence of coronavirus disease 2019 in patients with neuromyelitis optica in Isfahan, Iran, and a review on recent reports and literature.伊朗伊斯法罕视神经脊髓炎患者中2019冠状病毒病的患病率及近期报告和文献综述
Curr J Neurol. 2021 Jul 6;20(3):139-145. doi: 10.18502/cjn.v20i3.7689.
4
Outcome of COVID-19 Infection in Patients With Multiple Sclerosis Who Received Disease-Modifying Therapies: A Systematic Review and Meta-Analysis.接受疾病修正治疗的多发性硬化症患者感染新冠病毒的结果：一项系统评价和荟萃分析
J Clin Neurol. 2023 Jul;19(4):381-391. doi: 10.3988/jcn.2022.0348. Epub 2023 Mar 13.
5
COVID-19 susceptibility and outcomes among patients with neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis.视神经脊髓炎谱系疾病（NMOSD）患者的 COVID-19 易感性和结局：系统评价和荟萃分析。
Mult Scler Relat Disord. 2022 Jan;57:103359. doi: 10.1016/j.msard.2021.103359. Epub 2021 Nov 1.
6
Severe outcomes of COVID-19 among patients with multiple sclerosis under anti-CD-20 therapies: A systematic review and meta-analysis.抗 CD-20 治疗的多发性硬化症患者 COVID-19 的严重结局：系统评价和荟萃分析。
Mult Scler Relat Disord. 2022 Jan;57:103358. doi: 10.1016/j.msard.2021.103358. Epub 2021 Nov 5.
7
COVID-19 and vaccination against SARS-CoV-2 in patients with neuromyelitis optica spectrum disorders.COVID-19 与视神经脊髓炎谱系疾病患者的 SARS-CoV-2 疫苗接种。
Mult Scler Relat Disord. 2022 Jan;57:103320. doi: 10.1016/j.msard.2021.103320. Epub 2021 Oct 20.
8
Determinants of COVID-19-related lethality in multiple sclerosis: a meta-regression of observational studies.多发性硬化症患者 COVID-19 相关死亡率的决定因素：观察性研究的荟萃回归分析。
J Neurol. 2022 May;269(5):2275-2285. doi: 10.1007/s00415-021-10951-6. Epub 2022 Jan 4.
9
Increased risk of death from COVID-19 in multiple sclerosis: a pooled analysis of observational studies.COVID-19 导致多发性硬化症患者死亡风险增加：一项观察性研究的汇总分析。
J Neurol. 2022 Mar;269(3):1114-1120. doi: 10.1007/s00415-021-10803-3. Epub 2021 Sep 17.
10
The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis.COVID-19 感染在多发性硬化症（MS）患者中的流行情况：系统评价和荟萃分析。
Neurol Sci. 2021 Aug;42(8):3093-3099. doi: 10.1007/s10072-021-05373-1. Epub 2021 Jun 7.
本文引用的文献
1
Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis.新型冠状病毒肺炎合并多发性硬化患者的临床特征和结局。
JAMA Neurol. 2020 Sep 1;77(9):1079-1088. doi: 10.1001/jamaneurol.2020.2581.
2
COVID-19 pandemic: The experience of a multiple sclerosis centre in Chile.新冠疫情：智利一家多发性硬化症中心的经历
Mult Scler Relat Disord. 2020 Jul;42:102204. doi: 10.1016/j.msard.2020.102204. Epub 2020 May 16.
3
Evaluation of COVID-19 infection in patients with Neuromyelitis optica spectrum disorder (NMOSD): A report from Iran.视神经脊髓炎谱系障碍（NMOSD）患者中新型冠状病毒肺炎（COVID-19）感染的评估：来自伊朗的一份报告。
Mult Scler Relat Disord. 2020 Sep;44:102245. doi: 10.1016/j.msard.2020.102245. Epub 2020 Jun 1.
4
COVID-19 in MS: Initial observations from the Pacific Northwest.多发性硬化症中的新冠病毒病：来自美国太平洋西北地区的初步观察
Neurol Neuroimmunol Neuroinflamm. 2020 May 26;7(5). doi: 10.1212/NXI.0000000000000783. Print 2020 Sep 3.
5
An Italian programme for COVID-19 infection in multiple sclerosis.一项针对多发性硬化症患者新冠病毒感染情况的意大利项目。
Lancet Neurol. 2020 Jun;19(6):481-482. doi: 10.1016/S1474-4422(20)30147-2. Epub 2020 Apr 30.
6
Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic.在2019冠状病毒病大流行期间治疗多发性硬化症和视神经脊髓炎谱系障碍。
Neurology. 2020 Jun 2;94(22):949-952. doi: 10.1212/WNL.0000000000009507. Epub 2020 Apr 2.
Zotero 插件